Sahlgrenska Center for Cancer Research
Translational cancer research with the patient in focus
Here at Sahlgrenska Center for Cancer Research we focus our research with the patient in mind. This is so that the cancer patient could receive a better care in the future than in today’s society. Through a close collaboration with the Sahlgrenska University Hospital, we at the centre are trying to find new methods and treatments, which later can be tested and applied directly within the cancer care.
Our research groups work widely
Today our 25 research groups work in a wide spectrum of cancer related research questions, but they all have translational cancer research as a common denominator. Example of areas which are studied are brain cancers, lung cancer, breast cancer, melanoma, radiotherapy, prostate cancer and leukaemia. Other research areas at the centre are also epigenetics, ovarian and cervical cancer, sarcoma, neuroendocrine and thyroid cancers, pancreatic cancer and salivary gland tumors.
The research is in some cases used for developing diagnostic and prognostic tools, which in the longer term can improve the cancer care and ensure that the right treatments are being used.
Overbridging post graduate studies
Through the Cancer Research South (CARES) School we at Sahlgrenska Center for Cancer Research also provide courses within cancer research. As for our work, these courses are overbridging research and clinical work as well. CARES is a graduate research school which offers courses to PhD Students at University of Gothenburg and Lund University, which have both been part of the previous strategic program BioCARE.
Latest news
-
Health and medicineSRC starting grant for research on lung cancer cell migration to new sites
-
Health and medicineFive SCCR researchers receive VR grants2021
-
Health and medicineKa-Wei Tang receives SSMF’s LargeGrant
-
Health and medicineSEK 13 million from Lundberg ResearchFoundation
-
Health and medicineIncreased survival with eye melanoma in clinicaltrial
Latest SCCR publications
- Tissue architecture delineates field cancerization in BRAFV600E-induced tumor d… (External link)
- Average duration of prior treatment lines predicts clinical benefit to eribulin… (External link)
- Targeted Selected Reaction Monitoring Verifies Histology Specific Peptide Signa… (External link)
- Validation of a clinicopathological and gene expression profile model to identi… (External link)
- Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy… (External link)
- Intussusceptive Angiogenesis in Human Metastatic Malignant Melanoma (External link)
- Mucoepidermoid carcinoma of the salivary glands revisited with special referenc… (External link)
- SCC publications (before name change) (External link)
